Ipsen is a global biopharmaceutical company dedicated to delivering transformative medicines for patients in Oncology, Rare Disease, and Neuroscience. With nearly a century of experience, they leverage external innovation, operate in over 40 countries, and ensure access to their medicines in 88 countries.